GSK - GSK Plc - ADR
Close
43.91
0.170 0.387%
Share volume: 3,129,062
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$43.74
0.17
0.39%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-04-27 | 2022-07-27 | 2022-11-02 | 2023-03-10 | 2023-04-26 | 2023-07-26 | 2023-11-01 | 2024-03-05 | |
| Assets | |||||||||
| Total Assets | 117.631 B | 108.021 B | 66.985 B | 72.765 B | 72.630 B | 75.073 B | 74.233 B | 75.166 B | |
| Current Assets | 38.019 B | 65.736 B | 22.489 B | 25.126 B | 24.442 B | 24.428 B | 25.906 B | 23.751 B | |
| Inventories | 7.873 B | 5.658 B | 5.174 B | 6.226 B | 6.638 B | 6.959 B | 6.684 B | 7.004 B | |
| Other Current Assets | 882.669 M | 628.391 M | 890.714 M | 719.831 M | 521.830 M | 609.816 M | 576.918 M | 640.772 M | |
| Short Term Investments | 882.669 M | 628.391 M | 890.714 M | 719.831 M | 521.830 M | 609.816 M | 576.918 M | 640.772 M | |
| Total Receivables | 10.886 B | 7.833 B | 8.339 B | 8.533 B | 8.470 B | 8.555 B | 10.421 B | 9.408 B | |
| Current Cash | 18.331 B | 7.924 B | 7.953 B | 9.530 B | 8.646 B | 8.212 B | 8.151 B | 6.601 B | |
| Total Non-current Assets | 79.612 B | 42.285 B | 44.496 B | 47.638 B | 48.188 B | 50.645 B | 48.327 B | 51.416 B | |
| Property Plant Equipment | 13.068 B | 10.315 B | 9.886 B | 10.807 B | 10.856 B | 10.935 B | 10.750 B | 11.491 B | |
| Other Assets | 3.360 B | 2.908 B | 2.145 B | 2.276 B | 2.667 B | 2.596 B | 2.181 B | 3.212 B | |
| Intangible Assets | 39.960 B | 13.794 B | 17.313 B | 17.322 B | 17.551 B | 19.609 B | 18.655 B | 18.813 B | |
| Goodwill | 14.040 B | 7.165 B | 7.991 B | 8.524 B | 8.499 B | 8.479 B | 8.505 B | 8.677 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 117.631 B | 108.021 B | 66.985 B | 72.765 B | 72.630 B | 75.073 B | 74.233 B | 75.166 B | |
| Total liabilities | 96.409 B | 88.158 B | 56.820 B | 59.943 B | 57.979 B | 59.050 B | 58.215 B | 58.164 B | |
| Total current liabilities | 31.842 B | 45.898 B | 23.271 B | 27.596 B | 25.653 B | 27.913 B | 27.309 B | 26.839 B | |
| Accounts Payable | 0.000 | 0.000 | 0.000 | 4.677 B | 0.000 | 0.000 | 0.000 | 4.735 B | |
| Other liabilities | 12.965 B | 11.691 B | 12.170 B | 11.996 B | 11.966 B | 11.541 B | 11.536 B | 12.263 B | |
| Current long term debt | 5.380 B | 4.036 B | 3.102 B | 4.781 B | 5.282 B | 7.476 B | 5.907 B | 3.583 B | |
| Long term debt | 38.331 B | 22.787 B | 21.459 B | 20.609 B | 20.630 B | 19.637 B | 19.507 B | 19.370 B | |
| Other liabilities | 12.965 B | 11.691 B | 12.170 B | 11.996 B | 11.966 B | 11.541 B | 11.536 B | 12.263 B | |
| Minority interest | 8.461 B | 7.601 B | -484.229 M | -607.320 M | -629.667 M | -671.682 M | -626.926 M | -703.193 M | |
| Total Shareholder equity | 21.222 B | 19.863 B | 10.164 B | 12.821 B | 14.651 B | 16.023 B | 16.018 B | 17.003 B | |
| Common stock | 2.510 B | 2.013 B | 2.015 B | 1.515 B | 2.022 B | 2.027 B | 2.028 B | 2.028 B | |
| Retained earnings | 12.639 B | 11.918 B | 2.879 B | 5.278 B | 7.009 B | 8.103 B | 8.559 B | 9.222 B |